专题：Health Systems, Economic Evaluations, Quality of Life

This cluster of papers focuses on the intersection of health economics and quality of life assessment, with a particular emphasis on cost-effectiveness analysis, health utility measures such as EQ-5D and SF-36, quality-adjusted life years (QALY), health technology assessment, and preference-based measures for evaluating the economic impact of healthcare interventions.
最新文献
Impact of China’s National Drug Price Negotiation Policy on Availability, Affordability, and Regional Equity of Negotiated Drugs: A Multidimensional Nationwide Analysis, 2018 to 2021

article Full Text OpenAlex

The next decade in AMR: getting the basics right

article Full Text OpenAlex

Early access disparities in innovative therapies across the US, EU, China, and Japan

article Full Text OpenAlex

Safety assessment of Edaravone: A real-world adverse event analysis based on the FAERS Database

article Full Text OpenAlex

Reduction of visit-to-visit LDL-C intraindividual variability in patients treated with PCSK9 inhibitors and inclisiran vs standard lipid-lowering therapy

article Full Text OpenAlex

Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis

article Full Text OpenAlex

Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) for Treatment of Fibromyalgia: A Comprehensive Clinical Review

review Full Text OpenAlex

Methodology and Conflict of Interest Management: 2025 International Liaison Committee on Resuscitation Consensus on Science With Treatment Recommendations

article Full Text OpenAlex

Comparison of diagnostic characteristics of four frailty screening tools in maintenance hemodialysis patients

article Full Text OpenAlex

Global burden, quality of care, and cross-country inequalities in Alzheimer’s disease and other dementias from 1990 to 2021

article Full Text OpenAlex

近5年高被引文献
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

article Full Text OpenAlex 4365 FWCI940.97027088

2023 Alzheimer's disease facts and figures

article Full Text OpenAlex 2798 FWCI1055.08996163

Donanemab in Early Symptomatic Alzheimer Disease

article Full Text OpenAlex 2027 FWCI612.25019281

Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

article Full Text OpenAlex 1184 FWCI367.37290374

Multimorbidity

review Full Text OpenAlex 1111 FWCI248.43472044

Best practice guidance and reporting items for the development of scoping review protocols

article Full Text OpenAlex 1053 FWCI227.29161353

American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults

article Full Text OpenAlex 1037 FWCI292.87433961

The Overview on Effectiveness of Quality Enhancement for Enhancing Health Care and Professional Practice

article Full Text OpenAlex 959 FWCI957.68942132

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

review Full Text OpenAlex 827 FWCI187.75663075

The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials

article Full Text OpenAlex 793 FWCI283.95615587